Article

Characteristics of Patients with Newly Diagnosed High-Grade Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer in 2018–2023 and the Impact of Molecular Diagnostics on the Chemotherapy in Clinical Practice

2024-10-31

Abstract excerpt

High-grade advanced ovarian, fallopian tube and primary peritoneal (HGAOC) cancer are malignancies in which, apart from surgical treatment, systemic treatment plays an important role. The improvement in treatment results is associated with the introduction of polyADP-ribose polymerase inhibitors (PARPis). The aim of this study is to present a cross-section of patients treated for HGAOC, in one center, including th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: da60008a-5676-5f5c-96a5-d931c26b3f4b
DOI: 10.20944/preprints202409.0783.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Characteristics of Patients with Newly Diagnosed High-Grade Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer in 2018–2023 and the Impact of Molecular Diagnostics on the Chemotherapy in Clinical PracticeDOI 10.20944/preprints202409.0783.v2Read

PARP Inhibitors in the Management of Ovarian Cancer: ASCO GuidelineSemantic proximity Read

A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers.Semantic proximity Read

Molecular Pathogenesis Early Detection Strategies and Precision Therapeutic Advances in Ovarian CancerSemantic proximity Read

Rethinking ovarian cancer III: the past decade and future directions.Semantic proximity Read

Pamiparib for germline BRCA mutation-associated recurrent advanced ovarian, fallopian tube or primary peritoneal cancer.Semantic proximity Read

Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM).Semantic proximity Read

Dynamic changes in homologous recombination status before and after chemotherapy in advanced ovarian, fallopian tube, and primary peritoneal cancersSemantic proximity Read

Diagnostic histologique et moléculaire des cancers de l'ovaire - recommandations pour la pratique clinique Saint-Paul 2021: Histological and molecular diagnosis of ovarian.Semantic proximity Read

Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world studySemantic proximity Read

Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian CancerSemantic proximity Read

Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice.Semantic proximity Read

Untitled literature recordSemantic proximity Read